Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-127

All of this and we are not alone here is driven by supply and demand. The company has to make the demand by showing great results. The rest will follow and just remember our price and even at five times is still chicken feed for the bigger boys. The down times are the most difficult to cope with when you are subject to the vagrancies of mr market and the Don. Aburbes post about the potential of cbd related biotechs explains the situation rather well and make no mistake, this little BOT is way near the front in terms of progress. This is what upsets me personally with the SP but I do know that life changes in ten minutes in the market. I am hopeful this will happen to our bot. Do we look big in this as our bot is put on display?